Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Truong, H. Allbutt, M. Kassiou, J. Henderson (2006)
Developing a preclinical model of Parkinson's disease: A study of behaviour in rats with graded 6-OHDA lesionsBehavioural Brain Research, 169
R. Betarbet, T. Sherer, G. Mackenzie, M. Garcia-Osuna, A. Panov, J. Greenamyre (2000)
Chronic systemic pesticide exposure reproduces features of Parkinson's diseaseNature Neuroscience, 3
G. Paul, W. Meissner, S. Rein, D. Harnack, C. Winter, Kai Hosmann, R. Morgenstern, A. Kupsch (2004)
Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's diseaseExperimental Neurology, 185
A. Benazzouz, C. Tai, W. Meissner, B. Bioulac, E. Bézard, C. Gross (2004)
High‐frequency stimulation of both zona incerta and subthalamic nucleus induces a normalization of basal ganglia metabolic activity in experimental parkinsonismThe FASEB Journal, 18
K. Berger, S. Przedborski, J. Cadet (1991)
Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in ratsBrain Research Bulletin, 26
S. Przedbroski, M. Leviver, Hong Jiang, Mayra Ferreira, V. Jackson-Lewis, D. Donaldson, D. Togasaki (1995)
Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by instrastriatal injection of 6-hydroxydopamineNeuroscience, 67
V. Nair (2006)
Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson’s diseaseApoptosis, 11
U. Ungerstedt (1976)
6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.Pharmacology & therapeutics. Part B: General & systematic pharmacology, 2 1
S. Maesawa, Y. Kaneoke, Y. Kajita, N. Usui, Nobuaki Misawa, A. Nakayama, J. Yoshida (2004)
Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons.Journal of neurosurgery, 100 4
(2006)
Intersecting pathways to neurodegeneration in Parkinson’s disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein
F. Blandini, G. Nappi, C. Tassorelli, E. Martignoni (2000)
Functional changes of the basal ganglia circuitry in Parkinson's diseaseProgress in Neurobiology, 62
G. Breese, T. Traylor (1970)
Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.The Journal of pharmacology and experimental therapeutics, 174 3
Robert Hevner, Suyan Liu, M. Wong-Riley (1995)
A metabolic map of cytochrome oxidase in the rat brain: Histochemical, densitometric and biochemical studiesNeuroscience, 65
Mingxing Ouyang, Xun Shen (2006)
Critical role of ASK1 in the 6‐hydroxydopamine‐induced apoptosis in human neuroblastoma SH‐SY5Y cellsJournal of Neurochemistry, 97
F. Blandini, M. Armentero, R. Fancellu, E. Blaugrund, Giuseppe Nappi (2004)
Neuroprotective effect of rasagiline in a rodent model of Parkinson's diseaseExperimental Neurology, 187
J. Cadet, Reuben Last, V. Kostic, S. Przedborski, V. Jackson-Lewis (1991)
Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamenBrain Research Bulletin, 26
M. Armentero, R. Fancellu, G. Nappi, P. Bramanti, F. Blandini (2006)
Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's diseaseNeurobiology of Disease, 22
M. Armentero, R. Fancellu, G. Nappi, F. Blandini (2002)
Dopamine Receptor Agonists Mediate Neuroprotection in Malonate-Induced Striatal Lesion in the RatExperimental Neurology, 178
N. Nishino, N. Kitamura, T. Hashimoto, C. Tanaka (1993)
Transmembrane Signalling Systems in the Brain of Patients with Parkinson's DiseaseReviews in the Neurosciences, 4
D. Kirik, C. Rosenblad, A. Björklund (2000)
Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6‐OHDA lesion model depends on the site of administration of the trophic factorEuropean Journal of Neuroscience, 12
I. Kopin, S. Markey (1988)
MPTP toxicity: implications for research in Parkinson's disease.Annual review of neuroscience, 11
M. Wong-Riley (1989)
Cytochrome oxidase: an endogenous metabolic marker for neuronal activityTrends in Neurosciences, 12
Gerfen Gerfen (1992)
The neostriatal mosaic: multiple levels of compartmental organizationJ. Neural Transm. Suppl., 36
N. Uretsky, L. Iversen (1970)
EFFECTS OF 6‐HYDROXYDOPAMINE ON CATECHOLAMINE CONTAINING NEURONES IN THE RAT BRAINJournal of Neurochemistry, 17
G. Wooten (1997)
Functional Anatomical and Behavioral Consequences of Dopamine Receptor StimulationAnnals of the New York Academy of Sciences, 835
(2007)
Journal Compilation a Federation of European Neuroscience Societies and Blackwell Publishing Ltd
L. Siever, R. Cohen, A. Pert (2004)
Assessing pharmacologically induced dopamine receptor sensitivity changes with the ungerstedt turning modelPsychopharmacology, 75
R. Deumens, A. Blokland, J. Prickaerts (2002)
Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal PathwayExperimental Neurology, 175
F. Fornai, O. Schlüter, P. Lenzi, M. Gesi, R. Ruffoli, M. Ferrucci, G. Lazzeri, C. Busceti, Fabrizio Pontarelli, G. Battaglia, A. Pellegrini, F. Nicoletti, S. Ruggieri, A. Paparelli, T. Südhof (2005)
Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.Proceedings of the National Academy of Sciences of the United States of America, 102 9
Y. Ichitani, H. Okamura, Y. Matsumoto, I. Nagatsu, Y. Ibata (1991)
Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatumBrain Research, 549
N. Breysse, M. Amalric, P. Salin (2003)
Metabotropic Glutamate 5 Receptor Blockade Alleviates Akinesia by Normalizing Activity of Selective Basal-Ganglia Structures in Parkinsonian RatsThe Journal of Neuroscience, 23
R. Heikkila, B. Sieber, L. Manzino, P. Sonsalla (1989)
Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.Molecular and chemical neuropathology, 10 3
T. Bird (1993)
Are linkage studies boring?Nature Genetics, 4
T. Wichmann, M. DeLong (2003)
Pathophysiology of Parkinson's Disease: The MPTP Primate Model of the Human DisorderAnnals of the New York Academy of Sciences, 991
G. Snyder, R. Keller, M. Zigmond (1990)
Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.The Journal of pharmacology and experimental therapeutics, 253 2
B. Jeon, V. Jackson-Lewis, R. Burke (1995)
6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death.Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration, 4 2
Boris Spektor, David Miller, Z. Hollingsworth, Y. Kaneko, S. Solano, Jennifer Johnson, J. Penney, A. Young, R. Luthi-Carter (2002)
Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease.Brain research. Molecular brain research, 102 1-2
R. Heikkila, P. Sonsalla (1992)
The MPTP-treated mouse as a model of Parkinsonism: How good is it?Neurochemistry International, 20
J. Waddington, A. Cross, A. Longden, F. Owen, M. Poulter (1979)
Apomorphine-induced rotation in the unilateral 6-ohda-lesioned rat: Relationship to changes in striatal adenylate cyclase activity and 3H-spiperone bindingNeuropharmacology, 18
A. Flaherty, A. Graybiel (1993)
Output architecture of the primate putamen, 13
M. Carpenter, A. Jayaraman (1990)
Subthalamic nucleus of the monkey: connections and immunocytochemical features of afferents.Journal fur Hirnforschung, 31 5
D. Kirik, C. Rosenblad, A. Björklund (1998)
Characterization of Behavioral and Neurodegenerative Changes Following Partial Lesions of the Nigrostriatal Dopamine System Induced by Intrastriatal 6-Hydroxydopamine in the RatExperimental Neurology, 152
M. Bevan, N. Clarke, J. Bolam, Caroline Francis, P. Jays, Frank Kennedy, Liz Norman (1997)
Synaptic Integration of Functionally Diverse Pallidal Information in the Entopeduncular Nucleus and Subthalamic Nucleus in the RatThe Journal of Neuroscience, 17
B. Lavoie, A. Parent (1994)
Pedunculopontine nucleus in the squirrel monkey: Projections to the basal ganglia as revealed by anterograde tract‐tracing methodsJournal of Comparative Neurology, 344
B. Georgievska, D. Kirik, C. Rosenblad, C. Lundberg, A. Björklund (2002)
Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vectorNeuroreport, 13
F. Blandini, M. Garcia-Osuna, J. Greenamyre (1997)
Subthalamic Ablation Reverses Changes in Basal Ganglia Oxidative Metabolism and Motor Response to Apomorphine Induced by Nigrostriatal Lesion in RatsEuropean Journal of Neuroscience, 9
John Hudson, C. Horne, I. Strömberg, S. Brock, Jerry Clayton, Joseph Masserano, B. Hoffer, G. Gerhardt (1993)
Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned ratsBrain Research, 626
K. McNaught, D. Perl, A. Brownell, C. Olanow (2004)
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's diseaseAnnals of Neurology, 56
C. Altar, W. Boyar, Helen Kim (1990)
Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP.European journal of pharmacology, 181 1-2
L. Swanson (1984)
The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5Trends in Neurosciences, 7
B. Piallat, A. Benazzouz, A. Benabid (1996)
Subthalamic Nucleus Lesion in Rats Prevents Dopaminergic Nigral Neuron Degeneration After Striatal 6‐OHDA Injection: Behavioural and Immunohistochemical StudiesEuropean Journal of Neuroscience, 8
T. Murray, M. Messenger, M. Ward, S. Woodhouse, D. Osborne, S. Duty, M. O'Neill (2002)
Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's diseasePharmacology Biochemistry and Behavior, 73
F. Blandini, G. Nappi, J. Greenamyre (2001)
Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's diseaseAnnals of Neurology, 49
C. Gerfen (1992)
The neostriatal mosaic: multiple levels of compartmental organizationTrends in Neurosciences, 15
M. Gerlach, M. Gerlach, P. Riederer, H. Przuntek, M. Youdim (1991)
MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.European journal of pharmacology, 208 4
P. Salin, C. Manrique, C. Forni, L. Goff (2002)
High-Frequency Stimulation of the Subthalamic Nucleus Selectively Reverses Dopamine Denervation-Induced Cellular Defects in the Output Structures of the Basal Ganglia in the RatThe Journal of Neuroscience, 22
M. Vila, Richard Levy, M. Herrero, B. Faucheux, J. Obeso, Yves Agid, E. Hirsch (1996)
Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry studyNeuroscience, 71
R. Betarbet, Rosa Canet-Avilés, T. Sherer, P. Mastroberardino, C. McLendon, Jin-ho Kim, S. Lund, Hye-Mee Na, Georgia Taylor, Neil Bence, R. Kopito, B. Seo, T. Yagi, A. Yagi, G. Klinefelter, M. Cookson, J. Greenamyre (2006)
Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin–proteasome systemNeurobiology of Disease, 22
Katharine Hanrott, Louise Gudmunsen, M. O'Neill, S. Wonnacott (2006)
6-Hydroxydopamine-induced Apoptosis Is Mediated via Extracellular Auto-oxidation and Caspase 3-dependent Activation of Protein Kinase Cδ*Journal of Biological Chemistry, 281
N. Canteras, S. Shammah-Lagnado, B. Silva, J. Ricardo (1990)
Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the ratBrain Research, 513
RH Porter, JG Greene, DS Higgins, J. Greenamyre (1994)
Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion, 14
M. DeLong (1990)
Primate models of movement disorders of basal ganglia originTrends in Neurosciences, 13
B. Jeon, N. Kholodilov, T. Oo, Sang-yun Kim, K. Tomaselli, A. Srinivasan, L. Stefanis, R. Burke (1999)
Activation of Caspase‐3 in Developmental Models of Programmed Cell Death in Neurons of the Substantia NigraJournal of Neurochemistry, 73
B. Costall, C. Marsden, R. Naylor, C. Pycock (1976)
The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brainBrain Research, 118
Y. Ichitani, H. Okamura, D. Nakahara, I. Nagatsu, Y. Ibata (1994)
Biochemical and Immunocytochemical Changes Induced by Intrastriatal 6-Hydroxydopamine Injection in the Rat Nigrostriatal Dopamine Neuron System: Evidence for Cell Death in the Substantia NigraExperimental Neurology, 130
N. Nakao, M. Ogura, K. Nakai, T. Itakura (1998)
Intrastriatal Mesencephalic Grafts Affect Neuronal Activity in Basal Ganglia Nuclei and Their Target Structures in a Rat Model of Parkinson’s DiseaseThe Journal of Neuroscience, 18
B. Costall, R. Naylor, C. Pycock (1976)
Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.European journal of pharmacology, 35 2
U. Ungerstedt, T. Ljungberg, G. Steg (1974)
Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons.Advances in neurology, 5
N. Canteras, Sara Shammah-Lagnada, B. Silva, J. Ricardo (1988)
Somatosensory inputs to the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the ratBrain Research, 458
K. Nakano (2000)
Neural circuits and topographic organization of the basal ganglia and related regionsBrain and Development, 22
I. Divac, J. Mojsilovic-Petrovic, M. Lõpez-Figueroa, B. Petrović-minić, M. Møller (1995)
Improved contrast in histochemical detection of cytochrome oxidase: metallic ions protocolJournal of Neuroscience Methods, 56
F. Hefti, E. Melamed, B. Sahakian, R. Wurtman (1980)
Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPAPharmacology Biochemistry and Behavior, 12
R. Chaturvedi, S. Shukla, K. Seth, S. Chauhan, C. Sinha, Y. Shukla, A. Agrawal (2006)
Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's diseaseNeurobiology of Disease, 22
C. Lee, H. Sauer, A. Björklund (1996)
Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the ratNeuroscience, 72
H. Sauer, W. Oertel (1994)
Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the ratNeuroscience, 59
Despite the progressive development of innovative animal models for Parkinson's disease, the intracerebral infusion of neurotoxin 6‐hydroxydopamine (6‐OHDA) remains the most widely used means to induce an experimental lesion of the nigrostriatal pathway in the animal, due to its relatively low complexity and cost, coupled with the high reproducibility of the lesion obtained. To gain new information from such a classic model, we studied the time‐course of the nigrostriatal damage, metabolic changes in the basal ganglia nuclei (cytochrome oxidase activity) and behavioural modifications (rotational response to apomorphine) following unilateral injection of 6‐OHDA into the corpus striatum of rat, over a 4‐week period. Striatal infusion of 6‐OHDA caused early damage of dopaminergic terminals, followed by a slowly evolving loss of dopaminergic cell bodies in the substantia nigra pars compacta, which became apparent during the second week post‐injection and peaked at the 28th day post‐infusion; the rotational response to apomorphine was already present at the first time point considered (Day 1), and remained substantially stable throughout the 4‐week period of observation. The evolution of the nigrostriatal lesion was accompanied by complex changes in the metabolic activity of the other basal ganglia nuclei investigated (substantia nigra pars reticulata, entopeduncular nucleus, globus pallidus and subthalamic nucleus), which led, ultimately, to a generalized, metabolic hyperactivity, ipsilaterally to the lesion. However, peculiar patterns of metabolic activation, or inhibition, characterized the post‐lesional responses of each nucleus, in the early and intermediate phases, with peculiar response profiles that varied closely related to the functional position occupied within the basal ganglia circuitry.
European Journal of Neuroscience – Wiley
Published: Jan 1, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.